期刊文献+

1%盐酸布替萘芬乳膏治疗浅部真菌病疗效观察 被引量:7

Treatment efficacy of butenafine hydrochloride 1% cream for superficial mycosis
下载PDF
导出
摘要 目的观察和评价1%盐酸布替萘芬乳膏治疗浅部真菌感染疗效和安全性。方法门诊随机抽样,选择体股癣、手足癣患者,共236例,男164例、女72例,排除非观察对象,分为治疗组、对照组,平行对照。2组在性别、年龄、病程及感染严重程度上差异无显著性,具有可比性。治疗组使用1%盐酸布替萘芬乳膏,对照组使用2%酮康唑乳膏。将药物均匀涂于患处,1次.d-1。体股癣疗程2周,每周复诊1次;手足癣疗程4周,每2周复诊1次。所有患者停药2周后复诊1次,观察记录皮损改善程度,计算疗效指数,观察不良反应。结果体股癣经过2周治疗,治疗组完成观察治疗57例,有效率94.74%,对照组完成治疗48例,有效率91.67%;手足癣经过4周治疗,治疗组完成观察治疗46例,有效率93.48%,对照组完成观察治疗36例,有效率88.89%。2组不良反应轻微,其发生率:治疗组为3.89%、对照组为3.66%。结论1%盐酸布替萘芬乳膏是一种疗效好、安全性高、使用方便的治疗体股癣、手足癣的抗真菌药物。 Objective To investigate the efficacy and safety of butenafine hydroehloride 1% cream for superficial mycosis. Methods A total of 236 patients (164 men and 72 women), suffering from tinea corporis &cruris and tinea manuum & pedis were randomly sampled from the outpatients, who then were divided into 2 groups., a test group and a control group. The patients of the two groups were comparable in gender, age, course of disease, and degree of disease. Patients of the test group and the control group were treated with butenafine hydrochloride 1 % cream and keto conazole 2% cream, respectively. The affected areas were smeared with drugs once daily. Tinea eorporis and cruris were treated for 2 weeks and further consulted once a week. Tinea manuum and pedis were treated for 4 weeks and further consulted fortnightly. The improvement of skin lesions was observed, the treatment efficient index was calculated and the adverse reaction was observed 2 weeks after the drugs were stopped. Results After 2 weeks of treatment, the effective rate of tinea corporis & cruris was 94. 74%(57 patients treated in the test group), and 91.67% (48 patients treated in the control group). The cases of tinea manuum & pedis in the test group and control group after 4 weeks of treatment were 46 and 36, respectively. The effietive rate of the test group and the control group was 93.48% and 88.89%, respectively. Adverse reactions were minor, 3.89% and 3.66%, respectively. Conclusion Butenafine hydrochloride 1% cream is safe and effective for tinea corporis & cruris and tinea manuum & pedis.
出处 《中南药学》 CAS 2009年第3期230-232,共3页 Central South Pharmacy
关键词 体股癣 手足癣 1%盐酸布替萘芬 浅部真菌病 tinea corporis and cruris tinea manuum and pedis butenafine hydrochloride 1% cream superficial mycosis
  • 相关文献

参考文献11

  • 1何琪莹.抗真菌新药布替萘芬[J].国外医药(合成药.生化药.制剂分册),1999,20(3):178-180. 被引量:5
  • 2李劲松,宋诗铎.念珠菌对唑类药物耐药机制研究进展[J].国外医药(抗生素分册),2003,24(4):180-182. 被引量:18
  • 3Reyes BA,Beutner KR,Cullen SI,et al.Butenafine,a fungicidal benzylamine derivative,used once daily for the treatment of interdigital tinea pedis[J].Int J Dermatol,1998,37(3):450-453. 被引量:1
  • 4Greer DL,Weiss J,Rodriguez DA,et al.A randomized trial to assess once-daily topical treatment of tinea corporis with butenafine,a new antifungal agent[J].J Am Acad Dermatol,1997,37(2Pt1):231-235. 被引量:1
  • 5Savin R,De Villez RL,Elewski B,et al.One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis:a multicenter,double-blind trial[J].J Am Acad Dermatol,1997,36(2):15-19. 被引量:1
  • 6Tschen E,Elewski B,Gorsulowsky DC,et al.Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream[J].J Am Acad Dermatol,1997,36(2Pt1):9-14. 被引量:1
  • 7Odom RB.Update on topical therapy for superficial fungal rnfectrons,focus on butnafine[J].J Am Acad Dermatol,1997,36(2Pt1):1-2. 被引量:1
  • 8Tanuma H,Doi M,Ohta Y,et al.Butenafine hydrochloride(Mentax) cream for the tieatment of hyperkeratotic type tinea pedis and its transfer into the horny layer,with or without concomitant application of 20% urea ointment (Keratinamin)[J].Mycoses,2001,44(3):287-299. 被引量:1
  • 9Shelley WB,Shelley ED.Advanced Dermatologic Therapy I[J].Philadelphia:Saunders,2003,32(2):111-112. 被引量:1
  • 10王爱平,李若瑜,杨海珍,万哲,陈伟,朱学骏.1%盐酸布替萘芬溶液治疗趾间型足癣和体股癣随机双盲对照临床试验[J].中国临床药理学杂志,2001,17(5):344-347. 被引量:10

二级参考文献20

  • 1[1]Greer DL, Weiss J, Rodriguez DA, et al. A randomized trial to assess once-daily topical treatment of tinea corporis with butenafine, a new antifungal agent. J Am Acad Dermatol, 1997;37:231~235. 被引量:1
  • 2[2]Tschen E, Elewski B, Gorsulowsky DC, et al. Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream. J Am Acad Dermatol, 1997;36:S9~S14. 被引量:1
  • 3[3]Lesher JL Jr, Babel DE, Stewart DM, et al. Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled double-blind trial. J Am Acad Dermatol, 1997;36:S20~S24. 被引量:1
  • 4White T C. Increased mRNA Levels of EBG16, CDR, and MDRl correlate with increasea in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus[J]. Antimicrob Agents Chemother,1997,41:1482. 被引量:1
  • 5Marichal P, Bossche H V, Odds F C, et al. Molecular biological characterization of an azole - resistant Candida glabrata isolate[J]. Antimicrob Agents Chemother,1997, 41:2229. 被引量:1
  • 6Miyazaki H, Miyazaki Y, Geber A, et al. Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata [ J]. Antimicrob Agenta Chemother, 1998,42:1695. 被引量:1
  • 7Franz R, Kelly S L, Lamb D C, et al. Multiple molecular mechanisms contribute to a stepwise developmem of fluconazole redstance in clinical Candida albicans strains[J].Antimicrob Agents Chemother, 1998 , 42 : 3065. 被引量:1
  • 8Asai K,Tsuchimori N,Okonogi K,et al. Formantion of azole- resistant Candida albicans by mutation of sterol 14 - demethylase P450.[J].Antimicrob Agents Chemother, 1999,43(5):1163. 被引量:1
  • 9Sanglard D,Ischer F, Calabrese D, et al.The ATP binding camette transporter gene CgCDR1 from Candida glabrata Is involved in the resistance of clinical isolates to azole antifungal agents[J]. Antimicrob Agents Chemother , 1999,43:2753. 被引量:1
  • 10Aoyama Y,Kudo M,Asai K,et al. Emergence of fluconazole-resistant sterol 14 - demethylase P450 (CYP51) in Candida albicans is a model demonsuming the divenfification mechanism of P450[J].Arch Biochem Biophys,2000,379:170. 被引量:1

共引文献30

同被引文献32

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部